Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Hepatitis B core protein modulators

Hepatitis B core protein modulators

US Patent 10968211 · Granted Apr 6, 2021

Estimated economic value: $3,629,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Inhibitors of fibroblast growth factor receptor kinases2025
Inhibitors of the myst family of lysine acetyl transferases2025
Inhibitors of cysteine proteases and methods of use thereof2024
5-membered heteroaryl carboxamide compounds for treatment of HBV2024
5-membered heteroaryl carboxamide compounds for treatment of HBV2024
5-membered heteroaryl carboxamide compounds for treatment of HBV2024
Sigma ligand compounds and uses thereof2024
Inhibitors of the MYST family of lysine acetyl transferases2024
Monomers capable of dimerizing in an aqueous solution, and methods of using same2024
Hepatitis b core protein modulators2023
Hepatitis b core protein modulators2023
Hepatitis b core protein modulators2023